Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
Authors
Keywords
Cost-effectiveness, Economic evaluation, Osteoporosis, Risedronate, Treatment
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 30, Issue 3, Pages 649-658
Publisher
Springer Nature
Online
2019-01-30
DOI
10.1007/s00198-018-04821-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS
- (2017) A. Svedbom et al. OSTEOPOROSIS INTERNATIONAL
- The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France
- (2017) Mickael Hiligsmann et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
- (2016) Andréa Marques et al. CALCIFIED TISSUE INTERNATIONAL
- A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures
- (2016) Sarah Davis et al. HEALTH TECHNOLOGY ASSESSMENT
- Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France
- (2016) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- Changes in number and incidence of hip fractures over 12 years in France
- (2015) Karine Briot et al. BONE
- Residual effect after oral bisphosphonate treatment and healthy adherer effects—the Swedish adherence register analysis (SARA)
- (2014) O. Ström et al. OSTEOPOROSIS INTERNATIONAL
- A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
- (2014) Mickaël Hiligsmann et al. PHARMACOECONOMICS
- Health-Related Quality of Life and Utility Scores in People with Mental Disorders: A Comparison with the Non-Mentally Ill General Population
- (2014) Amélie Prigent et al. International Journal of Environmental Research and Public Health
- Health Technology Assessment in Osteoporosis
- (2013) Mickael Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
- (2013) Don Husereau et al. VALUE IN HEALTH
- Osteoporosis in the European Union: a compendium of country-specific reports
- (2013) A. Svedbom et al. Archives of Osteoporosis
- Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland
- (2012) K. Lippuner et al. OSTEOPOROSIS INTERNATIONAL
- Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland
- (2012) Mickaël Hiligsmann et al. VALUE IN HEALTH
- The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis
- (2012) Mickaël Hiligsmann et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
- (2011) François-Emery Cotté et al. BMC HEALTH SERVICES RESEARCH
- Predictors of institution admission in the year following acute hospitalisation of elderly people
- (2011) Moustapha Dramé et al. Journal of Nutrition Health & Aging
- Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
- (2011) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- A reappraisal of generic bisphosphonates in osteoporosis
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
- (2011) Mickaël Hiligsmann et al. PHARMACOECONOMICS
- Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications
- (2010) Mickaël Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients
- (2010) Mickaël Hiligsmann et al. HEALTH POLICY
- The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
- (2009) F. Borgström et al. OSTEOPOROSIS INTERNATIONAL
- Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis
- (2009) Mickaël Hiligsmann et al. VALUE IN HEALTH
- Utility Values Associated with Osteoporotic Fracture: A Systematic Review of the Literature
- (2008) Mickaël Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates
- (2008) Arlene M Gallagher et al. JOURNAL OF BONE AND MINERAL RESEARCH
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now